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a  b  s  t  r  a  c  t
Citrus  pectin  (CP),  a polysaccharide  composed  of [→4)--d-GalpA-(1→]n, was submitted  to  one  or  four
carboxy-reduction  cycles,  resulting  in  CP-CR1 and  CP-CR4, which  had  40%  and  2%  of GalpA  units,  respec-
tively.  The  polysaccharides  were  chemically  sulfated  and  their  anticoagulant  and  antithrombotic  effects
determined.  Sulfated  polysaccharides  (CP-S,  CP-CR1S  and  CP-CR4S)  had  different  anticoagulant  activi-eywords:
ulfated polysaccharides
itrus pectin
nticoagulant
ties,  doubling  APTT  at concentrations  of  28.7,  13.2,  and 4.9 g/ml  respectively.  CP-CR1S and  CP-CR4S also
showed  antithrombotic  activity  in  vivo  with  ED50 of 3.01  and  1.70  mg/kg,  respectively.  Like  heparin,  they
inhibited  thrombin  by  a mechanism  dependent  on  AT  and  HCII.  Their  hemorrhagic  potential  was  also
similar  to that  of  heparin.  According  to  methylation  analysis,  91.1%  and  50.2%  of 6-O-position  in CP-CR4S
and  CP-CR1S were  sulfated,  respectively.  Therefore,  substitution  of  carboxyl  groups  by  sulfate  esters  in
reasentithrombotic these  polysaccharides  inc
. Introduction
Venous thrombosis is a multifactorial disease characterized by
xcessive formation of clots in veins, without occurrence of any
ype of vascular injury. It affects 1 in every 20,000 people per year,
he risk increasing exponentially with age. The disease can present
tself in different ways, such as pulmonary embolism or deep vein
hrombosis. Risk factors for the development of thrombosis are
ivided into genetic factors and acquired, like immobility, preg-
ancy, and surgery (Fowkes, Price, & Fowkes, 2003; Rosendaal,
999). One of the most popular treatments of venous thrombo-
is is based on heparin, a highly sulfated glycosaminoglycan. Its
tructure is mainly formed by repeating disaccharide groups of
4)--d-glucosamine-(1 → 4)--l-iduronic acid(1→ (Mourão &
ereira, 1999; Petitou, Casu, & Lindahl, 2003).
The anticoagulant action of heparins takes place indirectly,
epending on the interaction of a speciﬁc pentasaccharide segment
ith antithrombin (AT). Thus, heparin facilitates the interaction of
T with thrombin and factor Xa (Mourão & Pereira, 1999). In addi-
ion to this mechanism, heparin also enhances thrombin inhibition
y heparin cofactor II (HCII), at higher concentrations, apparently
ndependently of a speciﬁc sequence of monosaccharides (Siè et al.,
989).
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Despite its popularity, the use of heparin as an anticoagulant
drug has limitations due to serious adverse effects that it may entail,
such as thrombocytopenia, bleeding, osteoporosis, skin rashes, con-
tact dermatitis, urticaria and skin necrosis, eosinophilia, among
others. In addition, due to its animal origin, biological contami-
nation by animal pathogens is a major concern (Longhi, Laks, &
Kalil, 2001; Mourão & Pereira, 1999; Perrinaud et al., 2006). Con-
sequently, attempts have been made to develop alternatives to
heparin, including studies with naturally or chemically sulfated
polysaccharides (Cipriani et al., 2009; Gracher, Cipriani, Carbonero,
Gorin, & Iacomini, 2010; Martinichen-Herrero, Carbonero, Gorin,
& Iacomini, 2005; Mourão & Pereira, 1999; Mourão, 2004; Pomin,
2009). Both anticoagulant and antithrombotic actions are related
to the presence of sulfate esters, their position and distribution
along the sugar-chain. Moreover, these properties are inﬂuenced
by the sugar type, glycosidic linkage of the sugar-chain and its
stereochemistry (Pomin, 2009).
Galactans from seaweeds and fucans from marine invertebrates
are the most common naturally sulfated polysaccharides that
have shown anticoagulant and antithrombotic activities (Fonseca,
Oliveira, Melo, Benevides, & Mourão, 2008; Melo, Pereira, Foguel, &
Mourão, 2004; Mourão & Pereira, 1999; Pereira, Mulloy, & Mourão,
1999; Yoon, Pyun, Hwang, & Mourão, 2007). Concerning chemical
sulfation, polysaccharides from different sources have been stud-
ied, including those from lichens, mushrooms, and plants (Cipriani
Open access under the Elsevier OA license.et al., 2009; Gracher et al., 2010; Martinichen-Herrero et al., 2005).
Recently, anticoagulant and antithrombotic effects of chem-
ically sulfated citrus pectin were demonstrated (Cipriani et al.,
2009). Citrus pectin (CP) is a widely available polysaccharide in
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ature, consisting almost entirely of →4)--d-GalpA-(1→ repeat-
ng units. CP has now been submitted to carboxy-reduction steps,
ollowed by chemical sulfation, and the inﬂuence of the sulfation
attern on anticoagulant and antithrombotic effects was investi-
ated.
. Experimental
.1. Materials
Citrus pectin was extracted from fresh mesocarp of Citrus
inensis (L.) Osbeck. Powdered material (100 g) was  submitted to
xtraction with 0.01 M HCl (500 ml)  under reﬂux for 1 h, followed
y ﬁltration, the ﬁltrate then being adjusted to pH 7.0 with aq.
aOH, dialyzed, and freeze-dried. Unfractionated heparin sodium
alt from porcine intestinal mucosa (202 IU/mg) was  obtained from
igma (St. Louis, MO,  USA).
.2. Methods
.2.1. Carboxy-reduction
Carboxy-reductions were performed by the carbodiimide
ethod (Taylor & Conrad, 1972), using NaBH4 as reducing
gent. Citrus pectin (500 mg)  was dissolved in 20 ml  of MES
uffer [2-(N-morpholine)-ethanesulfonic acid] (0.2 M,  pH 4.75), to
hich carbodiimide [cyclohexyl-3-(2-morpholinoethyl) carbodi-
mide] was added slowly with stirring, in a ratio of 24 mg  of
arbodiimide for each 1 mg  of uronic acid in the sample. The reac-
ion mixture was  stirred for a total of 2 h. 2 M Tris buffer (pH 7.0)
as added until pH 7.0 (10 ml)  and then NaBH4 to a ﬁnal concen-
ration of 2 M.  The reduction occurred over 14 h and was  stopped
y adding acetic acid to pH 5. The solution was ﬁnally dialyzed with
n 8 kDa cut-off membrane for 48 h, and the retained solution was
oncentrated and lyophilized. The citrus pectin was  subjected to
ne or four carboxy-reduction cycles, resulting in fractions CP-CR1
nd CP-CR4, respectively.
.2.2. Chemical sulfation
Citrus pectin (CP) and its carboxy-reduced derivatives (CP-CR1
nd CP-CR4) were chemically sulfated, resulting in samples CP-S,
P-CR1S and CP-CR4S, according to the method described by O’Neill
1955), which was slightly modiﬁed. The polysaccharides (100 mg)
ere then solubilized in formamide (10 ml), pyridine (10 ml)  was
hen added, followed by chlorosulfonic acid (in a proportion of
0 mol  of chlorosulfonic acid per mol  of free hydroxyl), which was
dded dropwise over 1 h at 0 ◦C. The mixture was maintained at 4 ◦C
or 12 h, and 10% (w/v) aq. NaHCO3 was added until effervescence
eased. The solution was then dialyzed and freeze dried.
.2.3. Structural analysis of polysaccharides
The average molar mass (Mw) of the polysaccharides was
etermined by high-performance size-exclusion chromatography
HPSEC) coupled to refractive index and multi-angle laser light
cattering detectors. Four ultrahydrogel columns in series, with
xclusion sizes of 7 × 106, 4 × 105, 8 × 104, and 5 × 103 Da, were
sed. The eluent was 0.1 M aq. NaNO2 containing 200 ppm aq. NaN3
t 0.6 ml/min. Each sample, previously ﬁltered through a mem-
rane (0.22 m),  was injected (100 l loop) at a concentration of
 mg/ml. The speciﬁc refractive index increment (dn/dc)  of the
olysaccharides was determined and the results were processed
ith software provided by the manufacturer (ASTRA 4.70.07, Wyatt
echnologies).Sugar composition was determined by GC–MS analysis of alditol
cetates. The polysaccharide (2 mg)  was hydrolyzed in 2 M TFA
1 ml)  at 100 ◦C for 8 h, the solution then evaporated, and the
esidue dissolved in water (1 ml). The hydrolyzate was  treated withymers 89 (2012) 1081– 1087
NaBH4 (2 mg), and, after 18 h, HOAc was added, the solution evapo-
rated to dryness and the resulting boric acid removed as trimethyl
borate by co-evaporation with MeOH. Acetylation was carried out
with Ac2O–pyridine (1:1, v/v; 1 ml)  at room temperature for 12 h,
and the resulting alditol acetate extracted with CHCl3. This was
analyzed by GC–MS (Varian Saturn 2000R-3800 gas chromatograph
coupled to a Varian Ion-Trap 2000R mass spectrometer), using a DB-
225 column (30 m × 0.25 mm i.d.) programmed from 50 to 220 ◦C at
40 ◦C/min, with helium as carrier gas. Components were identiﬁed
by their typical retention times and electron ionization spectra.
The uronic acid present on citrus pectin was  identiﬁed by silica-
gel 60 thin layer chromatography (TLC; Merck). CP was hydrolyzed
as described above and analyzed by TLC. The plates were developed
by ethyl acetate:n-propanol:acetic acid:water (4:2:2:1, v/v/v/v)
and stained with orcinol–sulfuric acid. Authentic standards of
glucuronic and galacturonic acids were used. The uronic acid
contents of the polysaccharides were quantiﬁed using the m-
hydroxybiphenyl colorimetric method (Filisetti-Cozzi & Carpita,
1991).
The sulfation pattern was  determined by methylation analysis.
The polysaccharides were solubilized in water, followed by addi-
tion of cation-exchange resin (H+ form), stirring for 30 min. The
solution pH was 1.0–2.0. The resin was  ﬁltered off, the ﬁltrate
neutralized with pyridine, and freeze-dried (Nagasawa, Inoue, &
Tokuyasu, 1979). The pyridinium salts were solubilized in Me2SO
(1 ml), followed by addition of powdered NaOH (300 mg)  and MeI
(1 ml)  (Ciucanu & Kerek, 1984). The mixtures were vigorously
shaken for 30 min  and then left for 24 h at rest. After neutraliza-
tion with HOAc, the samples were dialyzed with an 8 kDa cut-off
membrane and then freeze-dried. The per-O-methylated polysac-
charides were hydrolyzed with 0.5 ml  of 72% H2SO4 (w/v) for 1 h at
0 ◦C, followed by addition of water (4.0 ml)  and heating at 100 ◦C for
17 h (Saeman, Moore, Mitchell, & Millet, 1954). The hydrolyzates
were neutralized with BaCO3, ﬁltered, reduced with NaBD4 and
acetylated with acetic anhydride–pyridine (1:1, v/v; 1 ml)  for 14 h
at room temperature. The reactions were stopped by addition
of ice, and the partially O-methylated alditol acetates extracted
with chloroform, which was  washed several times with 5% aq.
CuSO4 (w/v) for elimination of residual pyridine. The partially O-
methylated alditol acetate mixtures were analyzed by GC-MS  using
the same conditions as described above for alditol acetates, except
the ﬁnal temperature was  215 ◦C. They were identiﬁed by their typ-
ical retention times and electron impact spectra (Sassaki, Gorin,
Souza, Czelusniak, & Iacomini, 2005).
2.2.4. Clotting assay (APTT)
The activated partial thromboplastin time (APTT) test was  deter-
mined with a Dade Actin kit (Dade Behring, Marburg, DE), in a
COAG-A-MATE XM coagulometer (OrganonTeknika Corporation,
Durhan, NC), using a pool of normal human plasma.
Plasma (90 l) was  incubated at 37 ◦C with saline, heparin, or
polysaccharides (10 l) and rabbit cephalin (100 l). After 2 min,
0.025 M CaCl2 (100 l) was  added, and the clotting time measured.
Results were expressed as T1/T0, which is the ratio between the clot-
ting time in the presence (T1) and absence of polysaccharide (T0) in
the incubation mixture ± standard error of the mean (SEM) (n = 2).
T1/T0 = 8.38 indicate complete inhibition of plasma coagulation.
2.2.5. Animals
Experiments were conducted on male or female Wistar rats
(170–250 g) from the colony of Federal University of Paraná,
Curitiba, Brazil. They were maintained under standard labora-
tory conditions (12 h light/dark cycle, temperature 22 ± 2 ◦C), with
standard pellet food and water ad libitum. The animals were anes-
thetized with an intramuscular injection of a mixture of ketamine
(100 mg/kg body weight) and xylazine (16 mg/kg). The Institutional
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tFig. 1. Elution proﬁles obtained on HPS
thics Committee of Federal University of Paraná approved all the
rocedures adopted in this study (authorization number 428).
.2.6. Venous thrombosis
Thrombus formation was induced by promoting a combination
f stasis and hypercoagulability (Berry, Girard, Lochot, & Lecoffre,
994; Vogel, Meleuman, Bourgondiën, & Hobbelen, 1989). Rats
ere anesthetized and their right carotid artery was cannulated
or injection of vehicle (saline), sulfated polysaccharides or heparin,
nd thromboplastin. The abdominal vena cava was dissected, and
oose sutures were placed between the right renal vena and femoral
eins, and in the left renal vena. Vehicle, sulfated polysaccharides,
r heparin were infused into the right carotid artery and allowed to
irculate for 5 min. Thrombus formation was then induced by injec-
ion of thromboplastin (5 mg/kg body weight), followed 20 s later
y stasis of a 0.7 cm segment of the abdominal vena cava, for 20 min.
he thrombus formed inside the occluded segment was then pulled
ut, washed with saline, dried for 1 h at 60 ◦C, and weighed. For each
roup (n = 6), the mean thrombus weight ± SEM was  determined
nd expressed as percentages of thrombus weight, 100% represent-
ng absence of any inhibition of thrombosis formation (thrombus
eight with vehicle administration).
.2.7. Inhibition of ˛-thrombin or factor Xa in the presence of
ulfated polysaccharides
The assays were performed in 96-well plates. The ﬁnal con-
entrations of the reactants included 100 nM antithrombin (AT)
r 15 nM heparin cofactor II (HCII), 6 nM -thrombin or 8 nM fac-
or Xa (Haematologic Technologies Inc., Essex Junction, VT, USA)
nd 0–100 g/ml sulfated polysaccharide in 75 l of TS/PEG buffer
0.02 M Tris/HCl, 0.15 M NaCl, and 1.0 mg/ml  polyethylene glycol
000, pH 7.4). The -thrombin or factor Xa was  ﬁnally added to
nitiate the reaction. After 1 min  of incubation at 37 ◦C, 25 l of
hromogenic substrate S-2238 for -thrombin or S-2222 for fac-
or Xa (Chromogenix AB, Molndal, Sweden) were added (100 M
nal concentration), and absorbance at 405 nm recorded over
5 min  (Inﬁnite M200, Tecan Group, Switzerland). The change of
bsorbance was proportional to the -thrombin or factor Xa activ-
ty. In the absence of sulfated polysaccharides, the thrombin activity
as considered 100%. Assays without AT and HCII were also per-
ormed.
.2.8. Hemorrhagic effect
Rats were anesthetized, and their right carotid artery was  can-
ulated for administration of vehicle (PBS, Phosphate Buffered
aline), heparin or polysaccharides. After circulation for 5 min, the
ails were cut 5 mm from their tip, and immersed in 40 ml  oflysis of CP, CP-S, CP-CR1S and CP-CR4S.
distilled water for 1 h. Determination of blood loss was established
by measuring spectrophotometrically the amount of hemoglobin
dissolved in water, compared to a standard curve obtained at
540 nm (Mendes-Silva et al., 2003). For each treatment group
(n = 6), the mean of blood loss volume ± SEM was  determined.
2.2.9. Statistical analysis
Results are expressed as the mean ± standard error of the mean
(SEM) and the statistical signiﬁcance of the results was deter-
mined using one-way analysis of variance (ANOVA), followed by
Tukey’s test. Data were considered different at a signiﬁcance level
of p < 0.05.
3. Results
3.1. Preparation and structural analysis of the sulfated
polysaccharides
Citrus pectin (CP) is a polysaccharide formed mainly by →4)-
-d-GalpA-(1→ repeating units. CP, extracted from mesocarp of C.
sinensis, contained essentially galacturonic acid (95.5%), which was
identiﬁed by TLC analysis and quantiﬁed colorimetrically. CP also
contained traces of neutral sugars: galactose (1.8%), glucose (1.5%),
arabinose (0.8%), and rhamnose (0.4%). It was subjected to one or
four carboxy-reduction cycles, resulting in fractions CP-CR1 and CP-
CR4, which contained 40% and 2% of GalpA units, respectively. Each
polysaccharide (100 mg)  was then chemically sulfated, giving CP-S
(145 mg), CP-CR1S (156 mg)  and CP-CR4S (195 mg).
In order to verify the integrity of the polysaccharide chains
after chemical sulfation, HPSEC analysis of CP, CP-S, CP-CR1S,
and CP-CR4S were performed, and their molecular weights
determined. Their elution proﬁles presented a main peak
between 40 and 55 min  (Fig. 1). Smaller peaks visualized after
55 min  may  represent fragments of the polysaccharides. The
molecular weights of CP, CP-S, CP-CR1S, and CP-CR4S were
120 kg/mol (dn/dc  = 0.142), 148 kg/mol (dn/dc  = 0.133), 132 kg/mol
(dn/dc  = 0.142), and 91 kg/mol (dn/dc  = 0.107), respectively.
According to methylation analysis (Table 1), CP-CR4S was 2-O-
(53.2%), 3-O- (55.5%) and 6-O-sulfated (91.1%), with more than one
third (36.6%) of the galactose units being tri-sulfated. CP-CR1S was
2-O- (22.9%), 3-O- (24.3%) and 6-O-sulfated (50.2%).
As fraction CP-CR1S contained 40% of GalpA units, it was
carboxy-reduced prior to methylation analysis, to determine the
sulfation pattern of its GalpA units. The proportion of alditol
acetates of resulting 3,6-Me2-Gal and 2,6-Me2-Gal increased after
carboxy-reduction, indicating that GalpA units of CP-CR1S were
2-O- (11.1%) and 3-O-sulfated (9.3%). However, according to the
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Table 1
Structural components of CP-CR4S, CP-CR1S and CP-CR1SCR, based on methylation analysis.
O-Methylalditol acetatea Mol  (%)b Substitution position
CP-CR4S CP-CR1S CP-CR1SCR
2,3,6-Me3-Gal 3.5 6.5 34.6 –
2,6-Me2-Gal 1.9 1.7 11.0 3-O-
3,6-Me2-Gal 1.5 1.6 12.7 2-O-
2,3-Me2-Gal 22.4 20.4 27.2 6-O-
2-Me-Gal 17.0 8.5 6.5 3-O- and 6-O-
3-Me-Gal 15.1 7.2 5.7 2-O- and 6-O-
Gal 36.6 14.1 2.3 2-O-, 3-O- and 6-O-
GalAc 2.0 40.0 – –
 reduction with NaBD4, and acetylation, then analysis by GC–MS (DB-225 column).
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Fig. 3. Venous antithrombotic effect after intravascular administration of sulfated
polysaccharides in rats. Thrombus formation was induced by promoting a combina-
tion  of stasis and hypercoagulability. Different doses of CP-CR4S (), CP-CR1S (©),
or  heparin () were administered in the right carotid artery and allowed to circulate
for  5 min. Thromboplastin (5 mg/kg body weight) was then injected and 20 s later,
0.7 cm of an isolated segment of the abdominal vena cava was tied off. After stasis
for  20 min, the thrombus formed on the interior was  pulled out, dried and weighed.a O-Methylalditol acetate, obtained by successive per-O-methylation, hydrolysis,
b Percentage of peak area relative to total peak area.
c Determined colorimetrically according to Filisetti-Cozzi and Carpita (1991) in a
elative increase of a 2,3,6-Me3-Gal derivative, 28.1% of GalpA units
f CP-CR1S had no sulfate group.
.2. In vitro anticoagulant activity of polysaccharides
The sulfated polysaccharides CP-S, CP-CR1S and CP-CR4S had
nticoagulant activity, being able to extend APTT in a dose-
ependent manner (Fig. 2), and doubling APTT at concentrations of
8.7, 13.2, and 4.9 g/ml, respectively (APTT control = 35.8 s). Non-
ulfated polysaccharides (CP, CP-CR1 and CP-CR4) did not affect
PTT.
.3. In vivo antithrombotic activity of sulfated polysaccharides
The antithrombotic effect of CP-S, CP-CR1S and CP-CR4S was
nvestigated by a venous thrombosis model, in rats. In the con-
rol group (vehicle), the average dried thrombus weight was
.2 ± 0.3 mg  (mean ± SEM), corresponding to 100% thrombosis.
P-CR1S and CP-CR4S inhibited thrombus formation in a dose-
ependent manner. CP-CR4S was more potent, with ED50 of
.7 mg/kg, while CP-CR1S had an ED50 of 3.01 mg/kg. Heparin, the
ositive control in the test, showed an ED50 of 0.06 mg/kg (Fig. 3).
owever, in the group treated with CP-S at dose of 5 mg/kg, the
verage dried thrombus weight was 5.45 ± 1.2 mg  (mean ± SEM),
hat was not statistically different from control group (vehicle).
ince CP-S has no antithrombotic effect in this high dose, other
oses were not tested.
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ig. 2. Anticoagulant activities measured by activated partial thromboplastin time
APTT). Normal human plasma was incubated with different concentrations of CP-
R4S, CP-CR1S, CP-S or heparin. Results are expressed as T1/T0, which is the ratio
etween the clotting time in the presence (T1) and absence of polysaccharide (T0)
n  the incubation mixture ± standard error of the mean (SEM) (n = 2). T1/T0 = 8.38
ndicate complete inhibition of plasma coagulation. All doses of polysaccharide CP-
R1S, CP-CR4S and heparin, as well as the CP-S doses of 20, 30 and 40 g/ml of
lasma, showed signiﬁcant differences with p < 0.001 compared with the negative
ontrol group (saline, 35.8 ± 0.0 s). The dose of 10 g/ml of CP-S showed p < 0.01.Results are expressed as % thrombus weight (mean ± SEM, n ≥ 6, *p < 0.05, **p < 0.01
and  ***p < 0.001 vs. saline), 100% representing absence of any thrombosis inhibition
(thrombus weight in the absence of polysaccharide administration).
3.4. Effect of sulfated polysaccharides on inhibition of ˛-thrombin
and factor Xa
Like heparin, CP-CR1S and CP-CR4S are able to inhibit -
thrombin and factor Xa in a serpin-dependent mechanism (Fig. 4
and Table 2). CP-CR1S inhibited -thrombin, in the presence of AT or
HCII, at IC50 of 2.9 × 10−3g/ml and 0.46 g/ml, respectively. How-
ever, CP-CR4S was  more effective, at IC50 of 1.0 × 10−3g/ml with
AT and 0.35 g/ml with HCII. Concerning factor Xa, CP-CR1S and
CP-CR4S had an IC50 of 0.46 g/ml and 0.11 g/ml, respectively, in
the presence of AT. However, the inhibitory effect on factor Xa was
slight, when compared with heparin with IC50 = 2.6 × 10−3g/ml.3.5. Hemorrhagic effect with sulfated polysaccharides
The hemorrhagic effect was evaluated using four times the dose
of polysaccharide required to inhibit 50% of thrombus formation.
Table 2
Concentrations of sulfated polysaccharides required to inhibit 50% of -thrombin
and  factor Xa in the presence of AT and HCII.
Polysaccharide IC50 (g/ml)
-Thrombin Factor Xa
With AT With HCII With AT
Heparin 9.5 × 10−4 0.53 2.6 × 10−3
CP-CR4S 1.0 × 10−3 0.35 0.11
CP-CR1S 2.9 × 10−3 0.46 0.46
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Fig. 4. Effect of sulfated polysaccharides on inhibition of -thrombin by AT (A), -
thrombin by HCII (B), and factor Xa by AT (C), 6 nM of -thrombin or 8 nM factor
Xa  and 100 nM AT or 15 nM HCII were incubated with different concentrations of
CP-CR4S (), CP-CR1S (©), or heparin (). After 1 min  at 37 ◦C, 100 M of speciﬁc
c
a
s
A
i
(
s
w
c
4
t
u
m
PBS Heparin CP-CR1S CP-CR4S 
0
20
40
60
80
100
120
0.24 mg/kg 12.04 mg/kg 6.80 mg/kg
B
lo
o
d
 v
o
lu
m
e
 (
µ
l)
Fig. 5. Hemorrhagic effect after intravascular administration of sulfated polysac-
charides in rats. CP-CR4S, CP-CR1S or heparin was administered in the right carotid
artery. The polysaccharide dose used was  four times that of ED50 obtained by the
antithrombotic test. After circulation for 5 min, the tails were cut 5 mm from their
tip, and immersed in 40 ml  of distilled water for 1 h. The determination of the bloodhromogenic substrate were added, and -thrombin or factor Xa activity, expressed
s  a proportion of absorbance at 405 nm (means, n = 3), with 100% of activity con-
idered to be that occurring without addition of polysaccharide.
lthough a visual analysis of the graph may  indicate an increase
n hemorrhagic process when polysaccharides were administered
Fig. 5), we found no statistically signiﬁcant difference on compari-
on with the control group (PBS). PBS was used as vehicle, because
ith saline there was copious bleeding. It is unknown why saline
aused this effect.
. DiscussionHeparin is largely effective for prevention and treatment of
hromboembolic problems. However, its anticoagulant effect is
npredictable, with risk of bleeding, requiring close laboratory
onitoring for its safe use (Mousa, 2007). In addition, due to itsloss was established by measuring the amount of hemoglobin dissolved in water,
by  spectrophotometric method, compared to a standard curve obtained at 540 nm.
animal origin, biological contamination by animal pathogens is a
serious concern (Mourão & Pereira, 1999). Consequently, attempts
have been made to obtain alternatives to heparin. It has been
demonstrated that chemical sulfation of polysaccharides can pro-
vide anticoagulant and antithrombotic agents (Cipriani et al., 2009;
Gracher et al., 2010; Martinichen-Herrero et al., 2005).
Studies have demonstrated that chemical sulfation of pectins,
including citrus pectin, give products with anticoagulant properties
(Bae et al., 2009; Cipriani et al., 2009), with the activity depending
on the quantity of sulfate groups (Fan et al., 2011; Vityazev et al.,
2010).
Citrus pectin is formed almost entirely by →4)--d-GalpA-(1→
repeating groups, and its chemical sulfation can lead to structures
2-O- and 3-O-sulfated. When carboxy-reduced, galacturonic acid
residues are converted to galactose, which can also be sulfated
at O-6. Thus, citrus pectin was submitted to one or four carboxy-
reduction cycles, resulting in two  polysaccharides with different
GalpA to Galp ratios, which were chemically sulfated and biologi-
cally tested as anticoagulants and antithrombotics.
Using different reagents for sulfation, Vityazev et al. (2010)
demonstrated that chlorosulfonic acid is the optimal reagent for
chemical sulfation of pectins, considering sulfation degree, destruc-
tion degree, and yield of sulfated derivatives. However, they
demonstrated that chemical sulfation with chlorosulfonic acid can
lead to partial destruction of the polysaccharide. So, since chloro-
sulfonic acid was  employed for chemical sulfation, acid hydrolysis
of the polysaccharides may  have occurred.
In order to verify the integrity of the polysaccharides, their
molecular weights were determined. The native polysaccharide CP
had a Mw of 120 kg/mol, whereas its sulfated derivative CP-S had a
Mw of 148 kg/mol. Glycosidic linkages including anomeric carbon
of uronic acids units are more resistant to acid hydrolysis. Thus,
the high content of GalpA in CP is responsible for its acid hydrolysis
resistance, and the increase of molecular weight is due to the addi-
tion of sulfate groups. Moreover, according to the protocol adopted,
chemical sulfation was  developed at cold temperature, avoiding a
high cleavage degree of the polysaccharides. To prepare CP-CR1S
and CP-CR4S, carboxy-reduction method was employed on CP and
its galacturonic acid units were converted to galactose units. CP-
CR1S still had a high GalpA content (40%) and apparently did not
present cleavage during the chemical sulfation procedure, since its
Mw was  132 kg/mol. Nevertheless, GalpA content of CP-CR4S was
only 2%, and its Mw was  91 kg/mol. It shows that reduction of GalpA
to Galp makes the polysaccharide more susceptible to cleavage.
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The sulfation patterns of the polysaccharides were determined
y methylation analysis, where O-methyl substitutes the free
ydroxyl groups. Sulfated hydroxyl groups are not methylated,
llowing the determination of their position. To determine the sul-
ation pattern of GalpA units of CP-CR1S, it was carboxy-reduced,
enerating CP-CR1SCR. This is necessary because the partially O-
ethylated alditol acetates derivatives of acid monosaccharides are
ess volatile and resistant to analysis by GC–MS. Therefore, accord-
ng to the analysis of CP-CR1SCR, the sulfation pattern of GalpA units
n CP-CR1S was indicated. As observed, chemical sulfation occurred
referably at 6-O-position over 3-O- or 2-O-positions, probably due
o stereochemistry of CP-CR1 and CP-CR4. Since CP was constituted
asically by GalpA units (95.5%), its 6-O-positions are unavailable
or sulfation. Then, although not quantiﬁed by methylation analysis,
ulfation of CP occurs at 2-O- and/or 3-O-position.
In order to determine if the polysaccharides had an anticoagu-
ant effect, the APTT test was employed, since it is used to monitor
atients undergoing anticoagulation therapy. All the chemically
ulfated polysaccharides extended APTT, suggesting that they can
ct as antithrombotics. The presence of sulfate groups is essential
o the activity of CP-S, CP-CR1S and CP-CR4S, since non-sulfated
olysaccharides (CP, CP-CR1 and CP-CR4) did not affect APTT. The
nticoagulant activity was dependent on the sulfation pattern of
he polysaccharides. With more sulfation at O-6, the polysaccha-
ide became more potent. The absence of 6-O-sulfate on CP-S may
xplain its low anticoagulant activity. In the thrombosis experi-
ent, CP-CR4S proved to be a more potent inhibitor of venous
hrombosis than CP-CR1S, whereas CP-S had no antithrombotic
ffect, showing again the positive effect of the 6-O-sulfate group.
The anticoagulant and antithrombotic effects of heparin are
ainly related to -thrombin and factor Xa inhibition by a mech-
nism dependent on AT and HCII (Bourin & Lindahl, 1993; Casu,
985). In order to determine if CP-CR1S and CP-CR4S act the same
ay as heparin, their effects on -thrombin and factor Xa activities
ere evaluated. Like heparin, they were able to inhibit -thrombin
nd factor Xa in a serpin-dependent mechanism. However, the
ffect on factor Xa was slight, indicating that CP-CR1S and CP-CR4S
ct preferentially inhibiting -thrombin (Table 2).
An ideal antithrombotic drug should inhibit thrombus forma-
ion, without increasing the risk of bleeding. Visual analysis of
ig. 5 may  indicate an increase in the hemorrhagic process when
olysaccharides were administered, but we found no statistically
igniﬁcant differences on comparison with the control group (PBS).
lthough heparin has been related to bleeding risk (Mousa, 2007),
his effect was not observed at the dose employed. The polysaccha-
ide dose used to evaluate the effect of bleeding was four times that
f ED50 obtained by the antithrombotic test. Thus, the results indi-
ate that administration of these polysaccharides does not cause
 hemorrhagic process, at these doses, and that they are poten-
ially safer with respect to their hemorrhagic potential. Although
he antithrombotic effect of CP-CR1S and CP-CR4S are slight when
ompared with heparin, there is a lower risk of a super dose, with
ower risk of bleeding.
Our results indicate that replacement of a carboxyl group
ith a sulfate group in citrus pectin increases anticoagulant and
ntithrombotic effects, without affecting the hemorrhagic effect.
t is known that the sulfation pattern of polysaccharides inﬂu-
nce their anticoagulant and antithrombotic activities (Pomin,
009). Sulfated galactans from red seaweeds have been studied
s anticoagulant and antithrombotic agents (Fonseca et al., 2008;
ereira et al., 2005). Those from Botryocladia occidentalis and Gelid-
um crinale have a very similar structure, composed of repetitive
isaccharide →4--d-Galp-(1 → 3)--d-Galp-(1→, with the same
ize chain, but they differ slightly in the sulfation pattern and
n the proportions of 2,3-di-O-sulfated and 3-O-sulfated -Galp
esidues, with the galactan from G. crinale being less sulfated. As aymers 89 (2012) 1081– 1087
consequence of these differences, the two  sulfated galactans differ
in their anticoagulant and antithrombotic activities (Fonseca et al.,
2008; Pereira et al., 2005). The sulfated galactan from G. crinale has
a lower anticoagulant activity when compared with the polysac-
charide from B. occidentalis (Pereira et al., 2005). Also, sulfated
galactan from B. occidentalis is a potent antithrombotic compound
in low doses, whereas that from G. crinale exhibits procoagulant
effect. In high doses, these effects are inverse. Carboxy-reduction
employed on this study converted citrus pectin in a (1 → 4)-linked
-d-galactan. Here, proportion and/or distribution of 6-O-sulfated
units may  be crucial for the anticoagulant and antithrombotic
effects of CP-CR1S and CP-CR4S. Moreover, CP-S, which is devoid
of 6-O-sulfated units, had low anticoagulant activity and has not
antithrombotic effect. Since galactans from seaweeds are struc-
turally different from those derived from citrus pectin, considering
glycosidic linkages and galactose anomers, a direct comparison
of their activities is not possible. However, as demonstrated for
seaweeds sulfated galactans, sulfation patterns affect the activity
of CP-CR1S and CP-CR4S. Since CP-CR4S was  more effective as an
anticoagulant and antithrombotic, stereospeciﬁc chemical sulfa-
tion protocols can be further employed to investigate the critical
structural motif responsible for promoting stronger effects.
Possible unintended pharmacologic consequences, like aller-
genic side-effects, can be associated with these chemically sulfated
polysaccharides. In this way, caution and new biological tests
are still necessary before they are employed. Even so, CP-CR4S
appears to be a promising antithrombotic agent, since it does not
involve bleeding risk and is obtainable from a widely available
source. Moreover, chemically sulfated polysaccharides can also be
an alternative to provide in vitro anticoagulation for use in clinical
laboratories.
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